S-1
S-1
- Company
- Compass Therapeutics, Inc.
- Filed
- August 11, 2020
- Accession Number
- 0001193125-20-216242
An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →